Join FCC at our June 13 Meeting
Sean Goddard of Viking Psychiatry. Certified Brain Health Professional. Discussing recent advancements in psychiatry including use of psychedelics.
https://vikingpsych.net/
"Glutamate, Growth, and the Future of Mood Disorder Care: NMDA Antagonists, Neuroplasticity, and TMS in Practice"
Description:
This presentation explores the transformative role of glutamatergic modulation in treating mood disorders, especially in treatment-resistant populations. We will break down the science behind NMDA receptor antagonism, the downstream effects on neuroplasticity, and how interventions like ketamine, esketamine, and transcranial magnetic stimulation (TMS) are reshaping clinical outcomes. Designed for practitioners on the front lines of psychiatric care, this session blends neurobiology with clinical pearls and emerging strategies to support faster, more durable recovery in patients with depression and related conditions.
Learning Objectives
By the end of this presentation, participants will be able to:
1. Describe the role of glutamate and NMDA receptor antagonism in the pathophysiology and treatment of mood disorders.
2. Compare the mechanisms, indications, and clinical use of glutamatergic agents including ketamine, esketamine, and Auvelity.
3. Explain how TMS promotes neuroplasticity and modulates glutamatergic circuits to improve treatment outcomes in mood disorders.
This presentation will NOT be recorded this month.
Fellowship is at 730am. Announcements and devotion will begin at 745am. One CEU will be provided (for 2025-26 members or those that purchase a single CEU ticket).
https://www.fellowshipofchristiancounselors.com/
